Home/Filings/4/0001493152-22-021863
4//SEC Filing

Ali Sarfaraz 4

Accession 0001493152-22-021863

CIK 0001138978other

Filed

Aug 9, 8:00 PM ET

Accepted

Aug 10, 1:01 PM ET

Size

5.6 KB

Accession

0001493152-22-021863

Insider Transaction Report

Form 4
Period: 2022-08-09
Ali Sarfaraz
Director
Transactions
  • Award

    Stock Option (right to buy)

    2022-08-09+39,48039,480 total
    Exercise: $1.90From: 2022-08-09Exp: 2027-08-09Common Stock (39,480 underlying)
Footnotes (1)
  • [F1]Represents a grant, pursuant to the issuer's 2021 Equity Incentive Plan, approved by the issuer's Board of Directors. The stock option vests, and becomes exercisable, with respect to 3,290 shares each month, beginning on the date of grant, until August 9, 2023.

Documents

1 file

Issuer

Novo Integrated Sciences, Inc.

CIK 0001138978

Entity typeother

Related Parties

1
  • filerCIK 0001937790

Filing Metadata

Form type
4
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 1:01 PM ET
Size
5.6 KB